Skip to main content
Clinical Trials/NCT04407572
NCT04407572CompletedNot Applicable

Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women

Kanuni Sultan Suleyman Training and Research Hospital1 site in 1 country44 target enrollmentStarted: April 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
44
Locations
1
Primary Endpoint
Serum zinc, vitamin d vitamin b12 deficiency levels

Study Overview

Brief Summary

Zinc d vitamin and b12 serum levels in covid-19 positive pregnants will be compared in terms of patients' responses to computed tomography and treatment.

Detailed Description

Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • covid-19 positive pregnant women
  • under 18 or more than 45 years old

Exclusion Criteria

  • vitamin D , Vitamin B12 or Zinc supplement use
  • Multivitamine use
  • have taken vitamin supplements in the past 3 months
  • use of medicines for vitamin deficiency
  • having metabolic disease covid-19 negative pregnant women

Outcomes

Primary Outcomes

Serum zinc, vitamin d vitamin b12 deficiency levels

Time Frame: 2 months

Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pınar Yalcin bahat

Principal Investigator

Kanuni Sultan Suleyman Training and Research Hospital

Study Sites (1)

Loading locations...

Similar Trials